Cargando…
Cell type specific gene delivery by lentiviral vectors: New options in immunotherapy
Many cells of the immune system are defined by distinct surface markers, which can be used to restrict gene delivery exclusively to a cell type of choice. This article explains recent findings about a CD8-specific vector that enhances the killing of tumor cells in TCR-based gene transfer strategies.
Autores principales: | Zhou, Qi, Buchholz, Christian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583925/ https://www.ncbi.nlm.nih.gov/pubmed/23483777 http://dx.doi.org/10.4161/onci.22566 |
Ejemplares similares
-
Immunotherapy with artificial adjuvant vector cells: Harnessing both arms of the immune response
por: Fujii, Shin-ichiro, et al.
Publicado: (2013) -
MAGE-A3-specific anticancer immunotherapy in the clinical practice
por: Brichard, Vincent G, et al.
Publicado: (2013) -
New insights into the role of NK cells in cancer immunotherapy
por: Salagianni, Maria, et al.
Publicado: (2012) -
A new approach for cellular immunotherapy of nasopharyngeal carcinoma
por: Smith, Corey, et al.
Publicado: (2012) -
Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
por: Tsuji, Takemasa, et al.
Publicado: (2012)